Background High-cholesterol diet induces atherosclerotic lesions which can be accelerated by denudation of endothelium (EC). EC denudation of iliac artery (IA) has not been well studied in the hyperlipemic rabbit….
Background TAVI is by now a valid therapeutic option in elderly patients (pts) with severe symptomatic aortic stenosis considered at high risk or with contraindication to aortic valve replacement (AVR)….
Background Patients often undergo coronary-artery bypass graft (CABG) within 5–7 days of thienopyridine therapy. Evidence supporting the use of on-treatment platelet reactivity testing before CABG is very limited. We hypothesized…
Background The introduction of transcatheter aortic valve implantation (TAVI) has led to a revival of balloon aortic valvuloplasty (BAV) as treatment of patients with severe aortic stenosis. Objectives This study…
Background The effect of percutaneous renal sympathetic denervation (RSD) on renal autoregulation, renal hemodynamics, and plasma catecholamines has not been adequately explored. In this study, we investigated the effect of…
Objective In this study, we investigated whether or not the number and function of endothelial progenitor cells (EPCs) were associated with the development of collateral formation in patients with single-vessel…
Introduction FFR measurement is a growing practice used to evaluate intermediate coronary lesions. Intracoronary (ic) bolus of adenosine or infusion is the preferred method of vasodilation; however, there is little…
Background and Aim Fractional flow reserve (FFR) is routinely used for coronary lesion assessment. Maximal coronary vasodilatation can be accomplished by intracoronary (IC) and intravenous (IV) adenosine (the gold standard),…
Background Bioabsorbable stents (BASs) have the potential advantages of reduction of late stent thrombosis and restoration of vasomotor function after disappearing from the treated coronary sites. Recently, discernible BVS (one…
Background Previous studies have described potential antiatherogenic effects of everolimus after systemic and local stent delivery. However, direct effects of everolimus on foam cells (FC) have not been well characterized….
